Navigation Links
Idenix Announces Data Presentations at the 2007 Digestive Disease,Week Meeting

miting (7%), influenza and influenza-like symptoms (7%), post-procedural pain (7%), diarrhea and loose stools (7%), and pharyngolaryngeal pain (5%). -- Grade 3-4 creatine kinase (CK) elevations occurred in 9% of TYZEKA- treated patients. -- The optimal duration of treatment with TYZEKA has not been established. The relationship of initial treatment response to outcomes such as hepatocellular carcinoma and decompensated cirrhosis are unknown.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, MA, is a biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by hepatitis B virus, hepatitis C virus and human immunodeficiency virus (HIV). For further information about Idenix, please refer to http://www.idenix.com .

Forward-looking Statement

This press release may contain "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995. Such forward- looking statements can be identified by the use of forward-looking terminology such as "will," or similar expressions, or by express or implied statements with respect to clinical trial development of telbivudine and valopicitabine. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantees that Idenix will successfully commercialize telbivudine, that TYZEKA(R) will ultimately be approved for sale by the European Commission, or in any additional markets, or that revenues from TYZEKA or any potential product will reach any particular level or that Idenix will
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Idenix Reports Results from Two Phase IIb Studies of the Combination of Valopicitabine and Pegylated Interferon in Hepatitis C Genotype-1 Patients at the 42nd Annual Meeting of the European Association for the Study of the Liver
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:8/31/2015)... -- Thousands of people will peacefully demonstrate their frustration ... epidemic at dozens of rallies across the country today. ... the United States has experienced skyrocketing rates ... heroin, yet the President has never once spoken publicly ... to President Obama , rally organizers compared his failure ...
(Date:8/31/2015)... 2015 With increasing clinical applications, the ... rise in active partnerships. The primary reason for ... quantitate CD4 cell markers in human immunodeficiency virus ... New analysis from Frost ... Market ( http://www.frost.com/nf0e ), finds the market earned ...
(Date:8/31/2015)... Aug. 31, 2015 The Wolf Administration today ... Pennsylvania State Police and local ... naloxone. Heroin and opioid overdose are the ... , killing more individuals than those involved in ... died from a drug overdose. " ...
Breaking Medicine Technology:Obama Administration's Neglect of Opioid Crisis Prompts Rallies in Many States 2Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 2Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 3Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 4Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 2Departments of Drug & Alcohol Programs and Health Announce Report 289 Pennsylvanian Lives Saved by Naloxone 3
(Date:8/31/2015)... ... August 31, 2015 , ... The 2015 New ... patients and family members, medical professionals, and researchers, covering a variety of topics ... is a collaborative effort between the Mesothelioma Applied Research Foundation and ...
(Date:8/31/2015)... BAY PINES, FL (PRWEB) , ... August 31, 2015 , ... ... accessible, high quality healthcare to Veterans residing across southwest Florida by hiring more doctors ... added to the list of expanded services. , In early July, Dr. Anthony Jabre ...
(Date:8/31/2015)... ... August 31, 2015 , ... David L. Chalnick, ... one of the first doctors in the area to perform minimally invasive hip ... been impressive: faster recovery, decreased immediate and long-term pain, and an accelerated return ...
(Date:8/31/2015)... , ... August 31, 2015 , ... Dr. Stewart ... may be prevented during Amblyopia Awareness Month. Only a comprehensive eye examination can diagnose ... common cause of visual impairment among children, affecting approximately 2 to 3 out of ...
(Date:8/31/2015)... ... ... The dental implant and prosthetic market in the U.S. is projected to reach $6.4 ... ) More than 30 million Americans are missing all their teeth in one or ... the National Association of Dental Laboratories (NADL) created the “What’s In Your Mouth?” campaign ...
Breaking Medicine News(10 mins):Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 2Health News:New York Experts on Mesothelioma Come Together at Memorial Sloan Kettering Cancer Center 3Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 2Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 2Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 3Health News:NJ Top Docs Presents, Dr. David L. Chalnick! 4Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 3Health News:Dental Association Raises Awareness as Implant Industry Grows 2Health News:Dental Association Raises Awareness as Implant Industry Grows 3Health News:Dental Association Raises Awareness as Implant Industry Grows 4
... Wednesday, July 7, 2010 In an effort to ... researchers from Wake Forest University Baptist Medical Center are partnering ... largest international trial ever sponsored by the US National Institute ... in the Elderly (ASPREE) study aims to assess whether aspirin ...
... News) -- Cosmetic contact lenses that give wearers an ... trend among teenagers and young adults," the American Academy ... The "circle" lens extends beyond the iris and, in ... among the young increased recently after pop star Lady ...
... Steven Reinberg HealthDay Reporter , TUESDAY, July 6 ... no relief for sufferers of chronic lower back pain caused ... seems to be another knock against glucosamine, with other recent ... ,I have suffered low back pain for a long time ...
... 1, 2010) -- Thousands of scientists and health professionals ... the 52nd meeting of the American Association of Physicists ... in Philadelphia, Pennsylvania. They will present the latest technological ... the safety and regulatory issues facing the field today. ...
... ... Eating Habits Among Children , ... Hartford, CT (Vocus) July 7, 2010 -- According to ... has tripled over the last 30 years and nearly one-third of the world’s ...
... ... a long-range, high performance wireless network at the Dawson Independent School District (DISD) of ... deliver wireless internet access on campus and soon to students living in low-income housing ... ...
Cached Medicine News:Health News:Can aspirin prolong a healthy life? 2Health News:Lady Gaga-Inspired Lens Fad Draws Warning From Eye Docs 2Health News: Glucosamine Ineffective for Lower Back Pain Linked to Arthritis 2Health News: Glucosamine Ineffective for Lower Back Pain Linked to Arthritis 3Health News:New Book Helps Combat America's Child Obesity Epidemic 2Health News:New Book Helps Combat America's Child Obesity Epidemic 3Health News:EnGenius Technologies, Inc. Delivers High Performance, Long Range Wireless Network to Dawson Independent School District 2Health News:EnGenius Technologies, Inc. Delivers High Performance, Long Range Wireless Network to Dawson Independent School District 3Health News:EnGenius Technologies, Inc. Delivers High Performance, Long Range Wireless Network to Dawson Independent School District 4
... a high performance temperature controlled shaker which ... speed and incubation time are fully programmable ... are displayed on the LCD in real ... the microplates provide uniform incubation with less ...
... The iEMS Incubator/Shaker HT ... Thus, the iEMS Incubator/Shaker HT ... as DNA hybridization and primer ... is available as a one-cabinet ...
The iEMS Incubator/Shaker is a high performance microplate incubator and orbital shaker. Its superior temperature control and efficient orbital shaking reduce incubation times. -...
Form: Cream-colored powder Moisture: 10% Ash: 6.5% Gel Strength (1.5%): 550 950 gm/cm 2 Gel pH (1.5%): 6.0 7.5 Gel Point (1.5%): 34 38C Melting Point (1.5%): 84 88C Application: Bacterial ...
Medicine Products: